ChemImage Sensor Systems (CISS) announces that Matthew P. Nelson, Ph.D, Chief Scientist and CISS Business Director will be presenting innovative results of the company's work on a portable standoff Hyperspectral Imaging (HSI) for detecting and identifying explosives, chemicals and narcotics at the SPIE Defense, Security and Sensing (SPIE DSS) meeting in Baltimore, MD.
Dr. Nelson's talk entitled, "Continued Development of a Portable Widefield Hyperspectral Imaging Sensor for Standoff Detection of Explosive, Chemical and Narcotic Residues" will be presented during the "Spectroscopy and Imaging for Explosives Detection I" session (Session 4 of Conference 9073) on Wednesday, May 7 in Room 348 of the Baltimore Convention Center. His discussion will provide attendees with an overview of the progress CISS is making in the development of VeroVision™, the next generation small, portable standoff HSI sensor.
"This presentation describes the work CISS is undertaking towards building a commercial HSI sensor platform for the detection of explosives, hazardous chemicals and narcotics. VeroVision™ will leverage all of CISS's experience in HSI to provide reliable detection of a wide variety of threats" said Dr. Nelson."
SPIE DSS is the industry's most important scientific conference and exhibition on optics, infrared imaging, lasers, and sensing for defense, security, industry, healthcare, and the environment.
About ChemImage Sensor Systems
CISS develops innovative products that utilize patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens.
ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
About ChemImage
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.
Media Contact: Tifanie Tiberio, ChemImage Corporation, 4122417335, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Source: http://www.chemimage.com/